AKT1 and neoplasm: In addition to familial or somatic genetic mutations that lead to relatively stable oncogenes, tumors also evolve mechanisms at the mRNA and protein levels, regulating the expression of PI3K/AKT, promoting tumor growth, and inducing resistance.